These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22794306)

  • 1. A systematic review of dydrogesterone for the treatment of threatened miscarriage.
    Carp H
    Gynecol Endocrinol; 2012 Dec; 28(12):983-90. PubMed ID: 22794306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of dydrogesterone for the treatment of recurrent miscarriage.
    Carp H
    Gynecol Endocrinol; 2015 Jun; 31(6):422-30. PubMed ID: 25765519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
    Kuptarak A; Phupong V
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dydrogesterone support in threatened miscarriage.
    El-Zibdeh MY; Yousef LT
    Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for threatened miscarriage.
    Qureshi NS
    Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.
    Lee HJ; Park TC; Kim JH; Norwitz E; Lee B
    Biomed Res Int; 2017; 2017():3616875. PubMed ID: 29392134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.
    Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH
    Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
    Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
    BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of progesterone on threatened miscarriage: Difference in drug types.
    Wang XX; Luo Q; Bai WP
    J Obstet Gynaecol Res; 2019 Apr; 45(4):794-802. PubMed ID: 30632226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
    Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis.
    Barbosa MWP; Valadares NPB; Barbosa ACP; Amaral AS; Iglesias JR; Nastri CO; Martins WP; Nakagawa HM
    JBRA Assist Reprod; 2018 Jun; 22(2):148-156. PubMed ID: 29488367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dydrogesterone in threatened abortion: pregnancy outcome.
    Omar MH; Mashita MK; Lim PS; Jamil MA
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pairwise and network meta-analysis comparing the efficacy and safety of progestogens in threatened abortion.
    Zhao H; He W; Yang Z
    Int J Gynaecol Obstet; 2022 Mar; 156(3):383-393. PubMed ID: 33864694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
    Stute P
    Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.